rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Sopheon Terug naar discussie overzicht

Sopheon juni 2021

31 Posts
Pagina: 1 2 »» | Laatste | Omlaag ↓
  2. Gartje 1 juni 2021 13:43

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Klopt het dat er na 26 mei geen aandeel meer gekocht en verkocht is!!! Wat zegt dit voor de cijfers deze maand!!
  3. abc123xyz987 1 juni 2021 16:40

    • abc123xyz987

      Lid sinds: 14 jul 2008

      Laatste bezoek: 24 dec 2024

    • Aanbevelingen

      Ontvangen: 42

      Gegeven: 2

    •    Aantal posts: 245

    Lang lang geleden zou je het antwoord " we gaan knallen!!" hebben gekregen. Weet niet meer wie dit was maar was wel een zeer positief ingestelde aandeelhouder.

    Ik wacht het rustig af.

    Groet ABC
  4. Gartje 2 juni 2021 07:55

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Tja ik heb me ook wel eens verloren in te rooskleurig denken, misschien is het altijd die hoop dat er iets spectaculairs gebeurt en dat je die koers richting die 15 pond ziet gaan. Dus blijf ik rustig zitten en hopen op dit scenario!
  7. Bertus S 2 juni 2021 10:02

    • Bertus S

      Lid sinds: 03 aug 2002

      Laatste bezoek: 19 feb 2024

    • Aanbevelingen

      Ontvangen: 4534

      Gegeven: 3919

    •    Aantal posts: 27.083

    Hier nog even het bericht van Sopheon zelf:

    Sopheon Announces Global Deployment of Enterprise Innovation Management Solution at The 3M Company
    3M manages its global portfolio of innovation and growth initiatives using Sopheon Accolade®

    Sopheon has today announced that The 3M Company (NYSE: MMM) a long-standing customer of the group, is using its Accolade software for new product development throughout its global enterprise. 3M’s cross-functional innovation teams rely on Sopheon Accolade to streamline processes, manage risk, optimize decision-making and accelerate time to market.

    3M produces over 60,000 products under several brands and is a leader in consumer products, safety and industrial, healthcare, transportation, and electronics. 3M’s deployment of Sopheon Accolade is enterprise-wide, including every division and business group across the company. This implementation involves thousands of users at all levels of the business, including research and development (R&D) scientists and researchers, manufacturing, supply chain, finance, sales and marketing, as well as commercialization managers and senior executives.

    “R&D is the heartbeat of 3M,” said Elizabeth Edblom, Ph.D., Director, Corporate Research & Development Global Strategy and New Growth at 3M. “Innovation is the thread that connects our four business groups to the vast amount of science conducted by the thousands of scientists and researchers we have around the world. The unprecedented enterprise-wide transparency provided by the Sopheon Accolade platform allows us to know what’s going on in new product commercialization before, during and after launch. Additionally, Accolade’s unique portfolio management capabilities provide business leaders with planning and performance insights required to govern the millions of dollars 3M invests in innovation. Finally, 3M is proud of our Sustainability Value Commitment for all new products – and Sopheon Accolade helps make that possible.”

    Accolade is Sopheon’s award-winning innovation management platform that connects people, systems and information across departments and functions. This collaboration and synchronization results in trusted, timely data for faster, better and more dynamic decision making. In addition to 3M, Sopheon Accolade has proven its value to thousands of other global users, such as Honeywell, Merck KGaA, P&G, Philips, BASF, Parker Hannifin and other innovation and market leaders across a wide variety of industries.

    “3M’s commitment to innovation is extraordinary,” said Greg Coticchia, CEO, Sopheon. “With 8,000 scientists and researchers working on 51 technology platforms in 650 different countries, it’s essential that they have a global system that allows engagement and visibility among all functions. In addition to enabling the alignment of strategy and execution, the configurability of Accolade allowed 3M to deploy a system that ensures the organization remains focused on outcomes and not processes.”

    For further information contact:

    Andy Michuda, (Executive Chairman)
    Arif Karimjee, (CFO) Sopheon plc + 44 (0) 1276 919 560

    www.sopheon.com/sopheon-announces-glo...

    Bertus S.
  8. marblesthegame 4 juni 2021 08:26

    • marblesthegame

      Lid sinds: 06 jul 2005

      Laatste bezoek: 01 feb 2025

    • Aanbevelingen

      Ontvangen: 355

      Gegeven: 723

    •    Aantal posts: 1.442

    RNS Number : 7668A
    Sopheon PLC
    03 June 2021

    SOPHEON PLC
    ("Sopheon" or the "Company")

    Issue of Equity - Option Exercise

    Sopheon plc, an international global leader in enterprise innovation management solutions, announces that, following the exercise of options by a former employee, it has issued and allotted 15,415 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 10 June 2021.

    The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,468,903. The Company does not hold any shares in treasury. Accordingly, the figure of 10,468,903 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
  10. abc123xyz987 9 juni 2021 21:14

    • abc123xyz987

      Lid sinds: 14 jul 2008

      Laatste bezoek: 24 dec 2024

    • Aanbevelingen

      Ontvangen: 42

      Gegeven: 2

    •    Aantal posts: 245

    quote:

    tritace schreef op 9 juni 2021 20:52:

    Wat denken jullie, morgen ivm de AVA nog een update over de business door de nieuwe voorzitter?
    Ja.

    Groet ABC
  14. abc123xyz987 10 juni 2021 08:06

    • abc123xyz987

      Lid sinds: 14 jul 2008

      Laatste bezoek: 24 dec 2024

    • Aanbevelingen

      Ontvangen: 42

      Gegeven: 2

    •    Aantal posts: 245

    www.londonstockexchange.com/news-arti...

    Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, holds its Annual General Meeting ("AGM") today. Given the Coronavirus situation, Shareholders are not expected to attend the meeting in person, and were encouraged in the notice to submit a proxy vote. The Board takes this opportunity to give shareholders the following update and review of the business.



    2020 in review



    We were proud to report a growth in contractual bookings in a year of unpredictability and unparalleled disruption. Revenue at $30m matched 2019, showing resilience, and several transformational indicators showed rising commercial traction, even in the face of two separate headwinds - the pandemic introduced new challenges to sales and retention; and our strategy to make selling new SaaS contracts a priority. Transition to SaaS contracts reduces revenue recognition in the first year compared to traditional perpetual licenses, trading this for a higher quality and predictable ongoing recurring revenue stream in the future. In spite of these challenges, Total Contract Value (TCV) of sales booked in the year was up almost a quarter, and we nearly tripled the TCV of new SaaS contracts booked. Six of the new deals signed exceeded $1m in initial TCV, and Annual Recurring Revenue (ARR) closed at $18m, an historic high up from $15.9m a year ago. As always, much of this activity concentrated into the fourth quarter. Retention was impacted during the initial stages of the pandemic, then rebounded later in the year. We achieved this while delivering a solidly profitable and cash generative year, also reporting new highs in cash balances and closing net assets. In parallel, we embarked on the development of new cloud-native products, which will bring value to personal and workgroup productivity alongside the corporate value points we are well known for. In addition, in early 2021, we introduced new leadership with the appointment of Greg Coticchia as CEO, Andy Michuda moving to the executive chairman role with a particular focus on partnerships and acquisitions, and Barry Mence stepping back to become a non-executive director. Our dividend was maintained at 3.25p per share, and is proposed to shareholders in today's meeting.



    Operational update



    Since the start of the year, under Greg's leadership we have continued to execute on our transformational strategy. This is exemplified by the recent appointments of Mike Bauer as Chief Product Officer, John Beischer as Americas VP of Sales, and Ann Marie Beasley as Chief Marketing Officer. Each one of these appointees bring an impressive track record and their experience, creativity, and drive will be valuable assets to Sopheon during this exciting period of transformation and growth. Mike has introduced over 100 products to market in his career, and offers deep experience in creating cloud-based solutions working across a range of companies, from start up to established enterprise such as Avnet and 3Com. John has led transformation efforts at various companies, from emerging enterprises to industry powerhouses like IBM and has an impressive record of creating and expanding industry leading go-to-market distribution channels in competitive and complex marketplaces. Ann Marie boasts an exceptional track record for developing and executing successful marketing strategies at companies like Allscripts, CA Technologies and Symantec.



    Another milestone was the launch of Accolade® for Smart Products, the first innovation management solution to bring together traditionally siloed software and physical product development - a new SaaS-based solution that enables companies to develop innovative digitally-enabled physical products in a new collaborative and efficient way with speed.



    Outlook



    We are pleased to report 27 software transactions closed so far this year, of which just under half were SaaS related. So far these have been mainly customer extension deals and smaller in size - metrics we expect to balance out through the year as normal with some new and larger deals in the pipeline. Customer retention has been strong; and coupled with new orders, ARR has risen above $19m compared to $18m at the end of 2020. Visibility for the full year 2021 now stands at $28m, compared to $23.2m at the time of our AGM announcement last year, which is very encouraging. In parallel with this continued evidence of commercial traction, we continue to see a strong appetite for innovation solutions. With our new senior appointments, we are undertaking a detailed review of our sales pipelines as companies work to find the new norm of conducting business post Covid. We are already seeing the benefits of alternative approaches and fresh ideas. Net cash at the end of May was $23.3m (2020: $21.3m), though a seasonal peak always occurs this time of year, it underlines our financial strength. These commercial and financial proof points give us the confidence to proceed with our strategy both in terms of operational expansion - we continue to hire and invest for growth - and with continuing our search of the right M&A candidates.
  17. [verwijderd] 10 juni 2021 11:19

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Volgens Finncap

    Sopheon*
    AGM statement and positive trading update
    Sopheon has reported a positive trading update for the period to date, including
    strong core KPIs: revenue visibility for the year of a record $28m for this time of
    year (85% of full-year forecasts, vs 77% covered this time last year, showing the
    benefit of increasing levels of SaaS revenue) and ARR of $19m, up from $18m
    since FY20 and +15% from $16.5m at 1H20. 27 deals (1H20: 13) include the typical
    modern mix of 50% SaaS, but mostly smaller extensions, with a still strong
    pipeline of new larger deals. With several senior appointments in addition to the
    March appointment of CEO Greg Coticchia, the balance sheet supports the
    strategic choices for the group, at a seasonal high cash position of $23.3m at the
    end of May, in line with FY expectations. We look forward to continued evidence
    of commercial traction, and reiterate our 1200p target price (4.2x FY22 EV/Sales).
  20. [verwijderd] 10 juni 2021 16:39

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Zou kunnen Arie, maar ik ben wat voorzichtiger; schat zelf 34/35.
    Vind overigens de reacties, incl. die van de koers, erg behoudend
    Omzet bij de koers een ruime 5000 op dit moment.

    Ik vond het een keurig eerste bericht van de nieuwe voorzitter. To the point en ter zake doend.
    Eens kijken wat augustus voor visible te melden heeft, dat zal wat meer richting geven.
  21. Gartje 10 juni 2021 17:17

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    De tijden dat je op goede vooruitzichten en cijfers 10 tot 15 procent stijgt lijkt voorbij, dan moet ik wel denken aan de woorden van Trinko dat de echte koersgroei er een beetje uit is.
    Dat ze een goede ontwikkeling laten zien staat buiten kijf!!
    Dus ik wacht dus rustig op de 12 pond.
31 Posts
Pagina: 1 2 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 6.997
AB InBev 2 5.479
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.112
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.445
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.622
Aedifica 3 900
Aegon 3.258 322.599
AFC Ajax 537 7.084
Affimed NV 2 6.287
ageas 5.844 109.883
Agfa-Gevaert 14 2.046
Ahold 3.538 74.287
Air France - KLM 1.025 34.972
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.017
Alfen 16 24.222
Allfunds Group 4 1.467
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 403
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.806
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.834 242.585
AMG 971 132.996
AMS 3 73
Amsterdam Commodities 305 6.685
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 481
Antonov 22.632 153.605
Aperam 92 14.885
Apollo Alternative Assets 1 17
Apple 5 375
Arcadis 252 8.731
Arcelor Mittal 2.033 320.441
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.279
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.060
ASML 1.766 105.280
ASR Nederland 21 4.450
ATAI Life Sciences 1 7
Atenor Group 1 465
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.579
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.383